MattenPlant Pte Ltd, a Singapore-based specialist in water treatment, has launched Southeast Asia’s first membrane technology-based Cold Water for Injection (Cold WFI) system. This initiative, unveiled at the Singapore International Water Week 2026, marks Matten’s strategic expansion into pharmaceutical water solutions, offering a locally assembled system backed by regional engineering support.
The Cold WFI system provides an energy-efficient alternative to traditional thermal distillation, meeting international pharmacopoeial standards. By eliminating continuous steam generation, it reduces energy consumption and operating costs, supporting sustainability goals through lower carbon emissions. This development comes as pharmaceutical manufacturing investments rise in Southeast Asia, increasing demand for compliant water infrastructure.
Victor Lim, CEO of MattenPlant, highlighted the region’s rapid growth in demand for efficient water systems, stating, “With our engineering depth, manufacturing capability, and regional presence, Matten is well positioned to be a trusted partner to pharmaceutical manufacturers in this part of the world.”
In addition to pharmaceutical solutions, Matten will showcase technologies addressing water quality and sustainability challenges across various sectors. These include a rapid bacterial analyser for Legionella risk monitoring and solutions for resource efficiency and emissions reduction.
The SIWW 2026 Water Expo runs from 16 to 18 June at the Sands Expo & Convention Centre, Singapore. Visitors can explore Matten’s offerings at Booth B2-D20 or visit their website for more information.
